Eliquis PDUFA date is 8/25/14 for the (supplementary) indications of acute VTE treatment and secondary VTE prevention: http://finance.yahoo.com/news/fda-accepts-review-eliquis-apixaban-220100204.html Note: This sNDA is distinct from the pending sNDA in primary VTE prevention, which has a PDUFA date of 3/15/14 (#msg-89831288).